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Long-Term Outcome After Open (OR) and
Endovascular Repairs (EVAR) of Abdominal Aortic
Aneurysms (AAAs) in Matched Cohorts Using
Propensity Score Modeling
Ying Huang, Peter Gloviczki, Gustavo S. Oderich, Audra
A. Duncan, Kalra Manju, Mark D. Fleming, William S.
Harmsen, Catherine E. Dvorak, Thomas C. Bower.
Division of Vascular and Endovascular Surgery, Mayo
Clinic, Rochester, Minn
Objectives: To compare long-term outcomes after
OR vs EVAR of AAAs at a tertiary center.
Methods: Clinical data of consecutive AAA patients
treated electively between 2000 and 2011 were
retrospectively reviewed. Primary endpoint was all-cause
mortality, secondary endpoints were complications,
reinterventions and ruptures. Propensity score-based
matching included age, gender, year of intervention
and comorbidities was performed to compare
outcomes.
Results: There were 1350 matched cohorts (mean age
74 6 7 years). Thirty-day mortality was 1.3% after OR,
1.0% after EVAR (P ¼ .40). Early complications were
lower after EVAR (13% vs 25%; P < .0001). Mean
follow-up was 4.2 years (30 days-12.7 years). At 5 years,
all-cause mortality was lower, freedom from reintervention
higher after OR (23% vs 32%, 87% vs 74%); freedom from
complications the same (66%). In multi-variable analysis,
SVS-comorbidity score and age were associated with all-
cause mortality. Results were similar in 1791 unmatched
cohorts. There were 2 ruptures after OR, 8 after EVAR
(P ¼ .02).
Conclusions: Both elective OR and EVAR have low
early mortality, EVAR has fewer early complications.
Advanced age and comorbidities predict high late
mortality. This study failed to support long-term beneﬁts
of EVAR, since the procedure was associated with
increased rates of late all-cause mortality, reinterventions
and small but deﬁnite risk of late rupture.
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Matched (n ¼ 1350)
OR (n ¼ 675) EVAR (n ¼ 675)
Male (%) 583 (86) 580 (86)
30-day mortality (%) 9 (1.3) 7 (1.0)
5-year all-cause mortality (%) 23 32
5-year rupture (%) 0 0.54PS28.
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Objectives: The optimal management of Type B
Aortic Dissection (TBAD) remains controversial in the
era of endovascular therapies. This study reports the
outcomes of different treatment paradigms for TBAD.
Methods: A retrospective review was undertaken of
all patients with TBAD from June 2006 to June 2012.
Demographics, hospital course and follow up visits were
analyzed. Patients who underwent surgical interventions
were compared to those with medical therapy. Survival
rates and predictors of outcome were determined using
the Kaplan-Meier method with Cox proportional
hazards.
Results: Out of 276 consecutive patients who were
hospitalized during this period with a conﬁrmed
thoracic dissection, 134 (48%) had TBAD. Sixty-two
(46%) were women and the mean age was 66.4 6
14.9. Median follow-up was 22.4 (0, 184) month.
Thirty-ﬁve patients underwent surgical intervention
with 20 Thoracic Endovascular Aortic Repair (TEVAR)
and open surgery in 15. The overall 30-day mortality
was 7% and cumulative survival rates at 1 year, 3 years
and 5 years were 85% (79, 91), 68% (59, 78) and
57% (47, 69) with no difference between medical vs
surgical groups (P ¼ .8) and TEVAR vs open surgery
group (P ¼ 1.0). Sixty-six (50%) patients developed
aneurysmal expansion, which required surgical interven-
tion in 26 (hazard ratios [HR], 0.99; P ¼ .96). Malper-
fusion and rupture only occurred in 5 (HR, 1.57; P ¼
.54) and 5 (HR, 3.64; P ¼ .01) patients respectively.
Multivariate analysis for overall survival found renal
insufﬁciency (HR, 2.6; P ¼ .004) and age (HR, 1.06;
P < .0001) were associated with greatest mortality.
Intramural hematoma was not a signiﬁcant predictor
of survival (HR, 0.49; P ¼ .11).
Conclusions: Medical therapy remains the mainstay of
treating TBAD with low morbidity and acceptable survival
rates. Surgical interventions including TEVAR are indi-
cated in selected patients with malperfusion or aneurysmal
expansion.
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Objectives: To generate a scoring system to grade the
risk of rupture of an abdominal aortic aneurysm (AAA) in
individual patients.
Methods: In a single hospital centre, a sequence of
vascular patients was enrolled between August 2011 and
December 2011. Abdominal aorta was classiﬁed as non-
aneurysmatic (<3 cm), aneurysmatic ($3 cm), or
ruptured AAA by angio-CT scan. Angio-CT scans were
coupled with a computational ﬂuid dynamics (CFD) eval-
uation performed using open source software
(ElmerSolver, CSC Institute of Technology, Finland).
CFD criteria studied were: the oscillatory shear index
(OSI), the time averaged wall shear stress (TAWSS) and
the residence relative time (RRT) on both 2D and 3D
models. AAA rupture predictors (clinical, aortic diameter
and CFD parameters) were analysed and a scoring system
was generated using Arabic numerals for all signiﬁcant
variables in order to grade the individual patient risk of
rupture.
Results: There were 143 patients examined. Mean age
of the patients was 74 years, 111 of the patiens were male.
73 patients suffered from an AAA (of which 18; 25% were
ruptured AAAs) and 52 had a non-aneurysmatic aorta. The
mean diameter and its standard deviation (SD) in the
normal aorta, AAA, and ruptured AAA groups were 2.06
(0.52) cm, 5.11 (1.67) cm, and 8.27 (2.13) cm respec-
tively (P > .001). The 2D OSI index was the best CFD
criterion following multivariate analysis and ROC curves
evaluation. An AAA was deemed at low, moderate, or
high risk of rupture, respectively, according to whether
the risk score was deﬁned as AAA I (when the total score
for all variables was <6), AAA II (6-14) or AAA III ($
15). The only protective factor was found in diabetes
(OR ¼ .760; CI: 0.643-0.897).
Conclusions: The risk score for AAA rupture herein
reported seems to be a useful tool to help predict AAA
rupture, but needs to be validated in independent cohorts
at a variety of centres before it can be recommended for
application, preferably in a randomized comparison with
other predictive models.
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Management of Symptomatic Thrombus in Non-
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Objectives: To report our experience of thrombo-
embolic disease from non-aneurysmal/atherosclerotic
aorta.
Methods: A retrospective review of 63 patients with
acute embolic lower limb or visceral ischemia from January
2012-December 2012 revealed Ten patients (M:F ¼ 4:6)
(mean age, 39.2 years) with a major thrombo-emboligenic
source within an otherwise normal aorta after thorough
evaluation of heart and great vessels.
In four patients thrombus was located in thoracic aorta,
2 in suprarenal abdominal aorta involving visceral vessels
and four in infrarenal aorta. End organs affected by acute
ischemia were: lower limbs (seven) (two bilateral) (L:R ¼
3:6), Visceral (three) (R Renal, one; SMA, two; celiac,
three)
Thrombus involving Thoracic aorta (n ¼ 4) were
treated with a stent-graft. In supra- renal abdominal aorta
both patients underwent laparotomy with trapdoor aortic
thrombo-embolectomy (Fig). Of the three patients with
infra renal aortic thrombus, one underwent covered stent-
ing, one underwent open aortic thrombectomy with inter-
position graft, one was managed on oral anticoagulants.
Post-thrombectomy, there was no underlying aortic wall
defect.
Results: One patient with small bowel and ascending
colonic ischemia required massive bowel resection died of
sepsis and multiorgan failure, one patient needed a below
knee amputation for irreversible ischemia. No patient had
any further embolic episode at a median follow up of 160
days.
Conclusions: Nonatherosclerotic, nonaneurysmal aortic
thrombus is an uncommon but important source of non-
cardiogenic embolus. It appears to occur in young adults.
Coverage of the aortic thrombus with a stent-graft, when
feasible, appears to be an effective and safe procedure.
When the thrombus lies adjacent to visceral vessels an
open trapdoor aortic thrombectomy, under direct visuali-
zation, is an effective solution to deal with the acute
ischemia and its cause.
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A Comparison of the Early, Transitional and Modern
Eras of Endovascular Aneurysm Repair (EVAR):
